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Abstract
Several bacterial pathogens decorate their surfaces with sialic
acid (Sia) residues within cell wall components or capsular
exopolysaccharides. Sialic acid expression can promote bacterial
virulence by blocking complement activation or by engagement
of inhibitory sialic acid-binding immunoglobulin-like lectins
(Siglecs) on host leukocytes. Expressed at high levels on splenic
and lymph node macrophages, sialoadhesin (Sn) is a unique
Siglec with an elongated structure that lacks intracellular signal-
ing motifs. Sialoadhesin allows macrophage to engage certain
sialylated pathogens and stimulate inflammatory responses, but
the in vivo significance of sialoadhesin in infection has not been
shown. We demonstrate that macrophages phagocytose the
sialylated pathogen group B Streptococcus (GBS) and increase
bactericidal activity via sialoadhesin-sialic-acid-mediated recog-
nition. Sialoadhesin expression on marginal zone metallophillic
macrophages in the spleen trapped circulating GBS and restrict-
ed the spread of the GBS to distant organs, reducing mortality.
Specific IgM antibody responses to GBS challenge were also
impaired in sialoadhesin-deficient mice. Thus, sialoadhesin rep-
resents a key bridge to orchestrate innate and adaptive immune
defenses against invasive sialylated bacterial pathogens.
Key message
& Sialoadhesin is critical for macrophages to phagocytose
and clear GBS.
& Increased GBS organ dissemination in the sialoadhesin-
deficient mice.
& Reduced anti-GBS IgM production in the sialoadhesin-
deficient mice.
Keywords Metallophillic macrophage . Antibody . Siglec .
Sialic acid
Introduction
The spleen is the largest secondary lymphoid organ in our
body, receiving 5 % of the cardiac output in blood perfusion,
and capable of screening the entire blood volume for patho-
gens within 20–30 min [1]. The crucial role of the spleen in
blood filtering is evident in asplenic individuals, who are
particularly vulnerable to sepsis with encapsulated bacteria
such as Neisseria meningitidis, Streptococcus pneumoniae,
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and Haemophilus influenzae [2, 3]. Opening of the arterial
blood stream into the marginal sinuses of the spleen reduces
blood flow so that pathogens in the systemic circulation can be
efficiently phagocytosed by marginal zone macrophages
(MZMs) and marginal metallophilic macrophages (MMMs)
[4, 5]. Depletion of MZMs and MMMs can result in patho-
gens escaping to the blood, potentially triggering uncontrolled
bacteremia and sepsis [6, 7].
MMMs, but typically not MZMs, express high levels of
sialoadhesin (Sn, sialic acid-binding immunoglobulin-like
lectin-1 (Siglec-1), CD169) and form an inner ring bordering
the marginal zone and the white pulp follicular areas. Among
Siglecs, Sn is unique in possessing 17 immunoglobulin-like
extracellular domains that may extend its length ∼40 nm
beyond the cell surface and recognize sialylated ligands found
on many sialylated pathogens, such as sialylated enveloped
viruses [8–10], bacteria [11, 12], and protozoa [13]. More
recently, Sn has been shown to capture killed sialylated
Campylobacter jejuni and able to promote rapid proinflam-
matory cytokine and type I interferon responses [14].
However, the consequences of Sn-dependent recognition of
an invasive sialylated bacteria pathogen on infection outcome
have not been addressed.
In this work, we used the sialylated pathogen group B
Streptococcus (GBS), a leading cause of human neonatal
sepsis and meningitis, as a model for in vitro and in vivo
analysis of Sn function. Specifically, we studied whether
expression of Sn in MMMs could facilitate splenic trapping
of GBS during early infection and/or influence later phase
humoral responses to coordinately combat this invasive
blood-borne pathogen.
Materials and methods
Bacteria and growth condition
GBS of serotypes Ia (A909), Ib (UAB), II (DK23), III (COH1,
K79 and D136), and VI (NT-6) are human neonate isolates.
COH1ΔNeuA mutant and isogenic COH1 mutants express-
ing different levels ofO-acetylation on the terminal sialic acid
(Sia) were previously described [15, 16]. GBS were grown in
Todd-Hewitt broth (Difco, BD Diagnostics) at 37 °C without
shaking. For functional assays, bacteria were cultivated at
37 °C to early log phase and resuspended to OD600 of 0.4 in
appropriate buffer to the desired concentrations.
Culture of mouse bone marrow-derived macrophages
(MBDMs) and in vitro stimulation with GBS
MBDMs were derived from marrow cells collected from
femur and tibia and cultured with conditioned media contain-
ing macrophage colony-stimulating factors (M-CSF) for
7 days. MBDMs were then seeded onto 24-well plates at 5×
105/well with M-CSF (10 ng/ml, R&D Systems) and
interferon-α (500 U/ml, PBL IFN Source) to optimize Sn
expression. For phagocytosis assays, 2.5×106 CFU GBS
DK23 was added to 5×105 macrophages (MOI=5).
Following a 30-min incubation, cells were washed, added
medium containing penicillin (5 μg/ml) and gentamicin
(100 μg/ml) to kill extracellular bacteria, detached by trypsin,
lysed with 0.025 % Triton X-100, and plated to enumerate
intracellular bacteria. For bacterial killing, 105 GBS DK23
was added to MBDMs at MOI=0.2 for 1 h, followed by
addition of 50 μl of 0.6 % Triton X-100 to lyse cells.
Recovered GBS were plated for CFU enumeration. For ex-
periments using Sn-neutralizing mAb (clone SER-4,
10 μg/ml), the mAb was added to cells 10 min prior to
inoculation with GBS. This neutralizing mAb has been shown
to block the sialic-acid-mediated interaction between Sn and
erythrocytes as well as the interaction between Sn and
sialylated meningococcal lipopolysaccharide [11, 17].
Flow cytometry analysis of Sn expression
MBDMs were stimulated with IFN-α (500 U/ml), LPS
(1 μg/ml, InvivoGen), lipoteichoic acid (1 μg/ml,
InvivoGen), GBS capsule (1 μg/ml, purified as described
[15]), or heat-killed GBS (108 CFU) for 2 days. Cells were
detached by 5mMEDTA/PBS, stained with FITC-conjugated
rat anti-mouse Sn (clone 3D6, Serotec), and analyzed by flow
cytometer (FACSCalibur, BD Biosciences).
Siglec-Fc binding assay
Siglec-Fc and FITC-labeled GBS binding studies were mod-
ified from a described method [18]. GBS was labeled with
0.1 % FITC/PBS for 30 min at 37 °C with rotation. Ninety-
six-well plates were coated with 1 μg/well protein A in
50 mM carbonate buffer (pH 9.5) overnight at 4 °C, washed,
and blocked with 1 % BSA/PBS for 1 h at room temperature.
Human and murine Sn-Fc (0.5 μg) (produced as described
[11]) was immobilized to individual wells for >3 h at room
temperature. FITC-labeled GBS (107) was added to each well,
and a 96-well plate was centrifuged and incubated for 30 min
at 37 °C. Initial fluorescence intensity was verified, and the
residual fluorescence intensity (excitation, 488 nm; emission,
530 nm) was measured using a CytoFluorII fluorescence plate
reader after extensive wash to remove unbound bacteria.
Immunofluorescence microscopy-based phagocytosis
analysis
GBS DK23 was labeled with PKH26 (Sigma) per manufac-
turer’s instruction. Labeled GBS (2.5×106 CFU) were added to
5×105 macrophages and incubated for 30 min. Macrophages
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were washed, fixed, permeabilized, blocked with BSA, and
stained with AlexaFluor 488® phalloidin (Life Technologies)
and DAPI for 30 min at room temperature. Images were
acquired using the Olympus FV1000 confocal microscope
and FV1000 Viewer software.
Intravenous GBS infection and visualization of GBS
in the spleen
All studies were approved by the UCSD Committee on the
Use and Care of Animals and performed using accepted
veterinary standards. Generation of Sn-deficient mice has
previously been described [19]. GBS DK23 was labeled with
5-(and-6)-carboxyfluorescein (Invitrogen) per manufacturer’s
instructions. Mice were intravenously infected with 2×
108 CFU of labeled GBS via tail vein. Kidney, lung, and
spleen were collected for CFU enumeration or frozen in
OCT solution 1 h after infection. Spleen cryostat sections
(5 μm) were fixed in acetone and blocked with 1 % BSA/
PBST and AVIDIN/BIOTIN blocking kit (Vector
Laboratories). The sections were stained with rat mAb anti-
mouse Sn (clone SER-4) with Alexa Fluor 647-conjugated
goat anti-rat IgG (Life Technologies) followed by second-step
staining with biotinylated rat mAb anti-mouse F4/80 (clone
CI:A3-1, Serotec) or B220 (clone RA3-6B2, BD Biosciences)
with Alexa Fluor 555-conjugated streptavidin (Life
Technologies). Images were from an Olympus FV1000 con-
focal microscope using FV1000 Viewer software.
GBS intraperitoneal infection mouse model
Wild-type (WT) and Sn-deficient mice (10–12 weeks) were
infected intraperitoneally with 108 CFU of GBS DK23 and
bacterial CFU in the blood monitored 4 h post-infection. To
detect anti-GBS antibody responses, mice (10–12 weeks)
were first injected with 0.5 mg of anti-Ly-6G mAb (clone
1A8, BioXcell) intraperitoneally to deplete neutrophils 24 h
prior to infection with 2×107 CFU of GBS DK23. Mouse
survival was monitored twice per day for 14 days at which
time mice were euthanized and their blood was collected for
antibody titer analysis.
ELISA of anti-GBS antibody isotypes
Fifty microliters of GBS (OD600=1.0) in 0.1 M sodium car-
bonate buffer (pH 9.5) was added into 96-well plates, spun at
2,000 rpm for 10 min, and incubated overnight at 4 °C. GBS-
coated plates were blocked with 3 % BSA/PBST for 1 h at
room temperature and then mouse sera was added in 3-fold
serial dilutions and incubated for 2 h at room temperature.
Antibody titers were determined with horseradish peroxidase-
conjugated immunoglobulin isotype-specific antibodies
(Southern Biotechnology) and TMB substrate solution. OD
450 nm was measured with a SpectraMax M3 microplate
reader.
ELISA of total antibody isotypes
Ninety-six-well plates were coated with goat anti-mouse
IgG+IgA+IgM (Southern Biotechnology, 0.5 μg/well in
0.1 M sodium carbonate buffer, pH 9.5) at 4 °C overnight.
Plates were blocked with 3 % BSA/PBST for 1 h, and sera
collected from GBS-infected mice was added (1:5,000 dilu-
tion for IgM and IgA; 1:50,000 dilution for IgG) and
incubated for 2 h at room temperature. Antibodies were
detected by horseradish peroxidase-conjugated immuno-
globulin isotype-specific antibodies and TMB substrate
solution. OD 450 nm was measured with a SpectraMax
M3 microplate reader.
Results
Sialoadhesin (Sn) binds to sialylated group B Streptococcus
(GBS), and its expression is upregulated by bacterial
components and inflammatory stimuli
GBS is a leading cause of neonatal pneumonia and sepsis, and
its surface capsular polysaccharide is invariably capped with a
terminal α2-3-linked sialic acid (Sia) known to impair phago-
cytosis and dampen neutrophil bactericidal activities via en-
gaging inhibitory Siglecs and to block complement deposition
[18, 20–23]. Sn, a unique Siglec possessing 17
immunoglobulin-like extracellular domains, has been reported
to recognize sialylated ligands found on many sialylated path-
ogens.We sought to determine if Sn could recognize GBS in a
Sia-dependent manner as a defense strategy to counteract
suppressive signals transduced by inhibitory Siglecs. Seven
GBS strains (A909, UAB, DK23, COH1, K79, D136, and
NT-6) tested here all bound to human Sn (hSn) and murine Sn
(mSn), but the Sia-negative COH1ΔNeuA mutant did not
(Fig. 1a).
Expression of Sn on human monocytes is upregulated by
IFN-α and agonists for Toll-like receptors [24]. In addition,
under infection or pathological conditions, expression of Sn
on circulating human monocytes and tissue macrophages can
be increased and correlated to disease progression [24–29].
We observed that IFN-α significantly increased Sn expression
on mouse bone marrow-derived macrophages (MBDMs), as
did lipopolysaccharide (LPS), lipoteichoic acid (LTA), GBS
capsular polysaccharide preparation, and heat-killed GBS
(HK GBS) (Fig. 1b). Upregulation of Sn expression during
infection could theoretically influence macrophage phagocyt-
ic and bactericidal activity against GBS.
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Sn is required for efficient uptake and clearance of GBS
To investigate the role of Sn in macrophage phagocytic and
bactericidal ability,MBDMswere culturedwith IFN-α for 2 days
to upregulate Sn expression prior to GBS infection. Compared to
Sn-deficient MBDMs, wild-type (WT) MBDMs showed greater
associationwith, and internalization of, live PKH26-labeledGBS
(Fig. 2a). Corroborating a critical role of Sn in GBS
phagocytosis, adding a Sn-neutralizing mAb significantly re-
duced the ability of WT MBDMs to phagocytose GBS to the
level of Sn-deficient cells (Fig. 2b). In addition, surviving GBS
were also significantly increased in the infected Sn-deficient cells
(Fig. 2c). To confirm if recognition of GBS capsular Sia by Sn
specifically contributes to macrophage phagocytic and bacteri-
cidal activity, we studied another GBS serotype III strain, COH1,
and isogenic mutants derived from this strain that either lack Sia
Fig. 1 Sn binds group B Streptococcus (GBS) and is upregulated by
inflammatory stimuli. a FITC-labeled GBS were added to plates coated
with human Sn (hSn), murine Sn (mSn), or control human IgG (hIgG).
Binding of bacteria to applied proteins was measured using a fluorescent
plate reader after extensive washes. Data shown are means±SEM and the
GBS binding difference between control and Sn was determined by two-
way ANOVA with Bonferroni post-test. ***P<0.001; **P<0.01;
*P<0.05. Experiments have been done with three biological replicates
and repeated twice. b MBDMs were stimulated with various bacterial
components or IFN-α for 2 days, stained with anti-Sn mAb, and subject-
ed to FACS analysis to examine Sn expression. Black thin line indicates
isotype control; gray thick line indicates anti-Sn mAb. Representative
data from one of the two reproducible independent experiments was
shown
954 J Mol Med (2014) 92:951–959
expression or express differing levels of Sia O-acetylation. O-
acetylation is known to interfere with Siglec-mediated Sia bind-
ing [15, 16]. WT MBDMs phagocytosed more WT GBS and
mutant GBS with reduced Sia O-acetylation than did Sn-
deficientMBDMs. On the other hand, GBS lacking Sia on their
capsule, or GBSwith high level ofO-acetylation on the capsule
Sia, were phagocytosed equally by WT and Sn-deficient
MBDMs (Supplementary Fig. 1A, B). Non-sialylated GBS and
GBS with reduced capsular Sia O-acetylation levels were killed
more efficiently byWTBMDMs than Sn-deficientmacrophages
(Supplementary Fig. 1C). Our findings demonstrate that Sn is
critical for macrophage recognition of GBS and contributes to
bactericidal activity against the sialylated pathogen.
Sn contributes to GBS capture and control of bacterial
dissemination in vivo
Splenic MZ macrophages are known to actively sample and
trap blood-borne pathogens. SinceMMMs express high levels
of Sn, we examined whether Sn facilitated MMM recognition
of GBS in vivo. 5-(and-6)-carboxyfluorescein-labeled GBS
were injected intravenously into mice, and the distribution of
GBS was visualized in the spleen co-stained with mAb anti-
mouse F4/80 (red pulp macrophage marker) and B220 (B cell
marker). Strong co-localization of GBS and Sn+ MMMs was
observed in WT animals, and the majority of the GBS were
found trapped within the MMMs, with minor spreading into
red pulp macrophages, probably due to direct deposit of GBS
via small branches of the central artery ending in the red pulp
[30] (Fig. 3A, left panel; right panel is for higher magnifica-
tion). Sn-deficient spleens were still able to capture GBS in the
marginal zone, which may reflect a contribution of MZMs or
other pattern recognition receptors expressed on the MMMs.
Notably, there were significant quantities of GBS identified
around the red pulp area; most of them colocalized with the
F4/80+ macrophages (Fig. 3a, middle panel), while no GBS
were observed in the white pulp B cell area of either theWTor
Sn-deficient spleens (Fig. 3b). An extended image set with
separated channel color is available in Supplementary Fig. 2.
In general, more GBS were identified in spleens of Sn-
Fig. 2 Sn contributes to phagocytic and bactericidal activity against
GBS. a Confocal microscopy images show significantly reduced phago-
cytosis of GBS in the Sn-deficient (Sn KO) MBDMs. Macrophages were
infected with GBS at MOI of 5 for 30 min and washed extensively before
staining cells with actin. Red indicates GBS. Green indicates actin. Blue
indicates nucleus. b Quantitative phagocytosis analysis. MBDMs were
infected with GBS in the presence or absence of Sn-neutralizing mAb,
followed by addition of antibiotics to only recover and enumerate
intracellular bacteria CFU. c Survival of GBS upon co-incubation with
MBDMs. Macrophages were infected with GBS at MOI of 0.2, and
surviving GBS was enumerated 1 h post-infection by serial plating.
Difference between two groups was calculated one-way ANOVA with
Tukey’s multiple comparison test (b) or by unpaired t test (c).
***P<0.001. Representative image (a) and data (b and c) were shown
from three independent experiments
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deficient mice compared to WT animals (Fig. 3a, b), as con-
firmed by quantitation of GBS colony-forming unit (CFU) in
the spleen (Fig. 3e). Consistent with the greater patrolling and
engagement of GBS by Sn+ MMMs in the WT animals,
reduced GBS CFUs were recovered from the WT kidney,
lung, and spleen (Fig. 3c–e). Our findings indicate that effi-
cient capture of GBS by Sn expressed onMMMs can facilitate
GBS clearance locally in the spleen and reduce the magnitude
of GBS dissemination to other organs.
Sn is important for survival and production of anti-GBS
antibodies in neutropenic mice
To date, there have been no in vivo studies addressing a role
for Sn in controlling active infection. Since expression of Sn is
required for macrophages to recognize and clear GBS in vitro
and in vivo, we examined whether Sn could impact mouse
survival upon GBS challenge. In normal mice, GBS was
efficiently removed from the circulation (at least five-log
reduction) within 1 h (Supplementary Fig. 3) after intravenous
challenge. Thus, a GBS intraperitoneal challenge model was
adapted to provoke systemic infection, as the bacterium can
gain access to the blood circulation via this route. WTand Sn-
deficient mice were infected intraperitoneally with GBS, and
blood CFU was enumerated 4 h later. As shown in Fig. 4a,
greater numbers of GBS were recovered from blood of Sn-
deficient mice, indicating impaired bacterial clearance.
However, whenmouse survival was monitored through 7 days
post-infection, no differences emerged between the two
groups (Fig. 4b). We hypothesized more abundant and rapidly
Fig. 3 Sn facilitates marginal metallophilic macrophage trapping of GBS
to limit pathogen dissemination. WT and Sn-deficient mice were intrave-
nously injected with 5-(and-6)-carboxyfluorescein labeled GBS, and
kidney, lung, and spleen were collected 1 h post-infection. Sections were
stained with mAb anti-mouse Sn, F4/80, and B220. Representative
images of spleen sections are shown in a and b. Scale bar is 100 μm
for all panels except 20 μm for the right panel of a. Comparison of
bacterial counts (expressed in CFU) recovered from the kidney (c), lung
(d), and spleen (e) of WT mice and Sn-deficient mice 1 h post-infection.
Difference between two groups was calculated by unpaired t test. Repre-
sentative data (n=3–4 mice each group) were shown from two indepen-
dent experiments
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mobilized host neutrophil response may obscure the impor-
tance of Sn in this model, since high levels of Sn expression
are restricted to MMMs and SCS macrophages in the spleen
and lymph nodes, respectively. To study the independent
contribution of Sn in control of bacterial infection in the
absence of neutrophils, neutrophils were depleted from mice
24 h prior to GBS infection. None of theWTmice died during
the 14-day period, but 40 % of the Sn-deficient mice died,
indicating that absence of Sn rendered mutant mice signifi-
cantly more susceptible to GBS infection under the neutrope-
nic condition (Fig. 4c).
Sn-deficient mice were previously reported to have an
intrinsic reduction in serum IgM amount [19]; therefore, we
asked whether serum Ig changes could be identified following
GBS challenge. As shown in Fig. 5a, serum IgM and IgG
amounts were reduced in the Sn-deficient mice. Since Sn is
critical for the phagocytosis of GBS, and SCS Sn+ macro-
phages can transfer antigens to initiate adaptive immune re-
sponses, we then further examinedwhether anti-GBS humoral
immune responses were altered in Sn-deficient mice. We
found a significant reduction of the anti-GBS IgM titer in
the Sn-deficient mice (Fig. 5b), while similar anti-GBS IgG
titers were observed in the two groups (Fig. 5c). Reduced anti-
GBS IgMs may further increase the susceptibility of Sn-
deficient mice to GBS infection in addition to impairment of
immediate innate immune responses, such the macrophage
phagocytosis and bactericidal activity.
Discussion
Efficient pathogen elimination is crucial for the host and will
determine the extent and pathological consequences of infec-
tion. To combat blood-borne infectious microbes, the spleen is
poised to quickly sample and trap circulating pathogens in
strategically localized MZMs and MMMs [31]. These rapid
innate immune mechanisms help reduce pathogen load until
an adaptive immune response, more specific but temporally
delayed, is mounted. Here, we provide the in vivo demonstra-
tion of Sn function in defense against an invasive sialylated
Fig. 4 Sn is important for mouse survival during neutropenia. WT and
Sn-deficient mice were intraperitoneally infected with GBS; blood was
collected 4 h post-infection for CFU enumeration (a); and survival was
monitored for 7 days (b). WT and Sn-deficient mice were intraperitone-
ally challenged with GBS after neutrophil depletion, and the survival was
recorded for 14 days with n=10 for WT and n=9 for Sn-deficient mice
(c). Long-rank test was used for statistical analysis for (b) and (c).
Representative data were shown from two independent experiments
Fig. 5 Sn is important for production of anti-GBS antibodies during
neutropenia. a Decreased total IgM and IgG serum levels after GBS
challenge in Sn-deficient mice. Total serum immunoglobulins from
GBS-infected mice were measured by isotype specific ELISA (n=8 for
WT and n=9 for Sn-deficient mice). Mann-Whitney test was used for
statistical analysis. Anti-GBS IgM (b) and anti-GBS IgG (c) titers were
measured from GBS-infected WT (filled blue circle, n=8), GBS-infected
Sn-deficient (open red circle, n=9), and uninfected WT mice (filed black
circle, n=6). Difference among groups at each dilution was tested by one-
way ANOVAwith Tukey’s multiple comparison test. ***P<0.001. Rep-
resentative data were shown from two independent experiments
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bacterial pathogen. This specialized macrophage Siglec not
only provides innate immune functions such as phagocytosis
and bactericidal activities but also supports the development
of proper humoral responses against the microbe.
Most Siglecs have one or more immunoreceptor tyrosine-
based inhibitory motifs (ITIMs) in the cytosolic tail and func-
tion as inhibitory receptors. Sialylated pathogens can even
exploit ITIM-containing Siglecs to dampen innate immune
responses therefore to enhance their survival [18, 32, 33], in
addition to reduce complement deposition and activation on
the bacterial surface to impair opsonophagocytosis [20, 21]. In
contrast, Sn, upregulated upon infection, recognizes the very
same Sia epitope and helps preserve a critical innate immune
function of these phagocytic cells. As a consequence, Sn has
the right properties to mediate critical initial contacts with
sialylated pathogens to function directly as a phagocytic re-
ceptor or to coordinate with other pattern recognition recep-
tors to mediate efficient phagocytosis. Our data supports this
idea showing that applying anti-Sn-neutralizing mAb nearly
eliminated the phagocytic ability and significantly reduced the
bactericidal activity of macrophages, even as they are expect-
ed to express numerous other pattern recognition and scaven-
ger receptors (Fig. 2b).
The humoral response provides protective circulating anti-
bodies to neutralize or coat pathogens and facilitate subse-
quent opsonophagocytosis. The ability of B lymphocytes to
interact with an antigen involves antigen-trapping, depositing,
and transport systems localized to the major antigen entrance
site. Splenic MZ macrophages can facilitate antibody produc-
tion by transferring antigen captured from the circulation to
MZ B cells [4, 34]. In addition, migration of splenic follicular
B cells to the outer follicle is induced upon binding of
oxysterol produced by MMMs [35–37]. SCS Sn+ macro-
phages in the LNs transport antigens to invariant natural killer
T cells, dendritic cells, and B cells and thus promote the
immune responses against invaders [38–40]. Taking all the
factors together, we speculate that MMMs are not only re-
quired for early antigen trapping and clearance but may also
represent a crucial compartment for antigen transferring to B
cells and follicular dendritic cells. Although Sn-deficient mice
had MMMs located in the right location, they exhibited a
small decrease of B220+ cells in the spleen and reduction of
serum IgM levels [19]. In response to GBS challenge, Sn-
deficient animals showed reduced total serum IgM levels and
specific anti-GBS IgM antibodies. Although the production of
anti-GBS IgG antibodies was not altered in those Sn-deficient
animals, they had reduced total serum IgG levels after GBS
challenge. Our findings suggest that expression of Sn on
MMMs is required for them to elicit specific humoral re-
sponses to counteract invading pathogens.
Whether through specific de novo biosynthesis, scaveng-
ing, or precursor scavenging, many pathogens including GBS,
C. jejuni, H. influenzae, Neisseria gonorrhoeae, Neisseria
meningitides, Escherichia coli K1, and Pasteurella multocida
can display Sias on their cell surface as a method of molecular
mimicry, counteracting complement activation and/or engag-
ing inhibitory ITIM-bearing Siglecs on leukocytes. The spe-
cialized macrophage Sn receptor has a conserved binding
specificity that happens to mirror the type and linkages of
Sias expressed by the pathogens mentioned above.
Understanding how Sn promotes Sia-dependent phagocytosis
and stimulates antibody responses during such infections
highlights an additional complexity in the evolutionary arms
race between pathogen and host immune defense, wherein
microbial glycan expression and its recognition strongly in-
fluence outcome.
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